Cathepsin B, p53 expression and AgNORs in transitional cell carcinoma

Neoplasma

Volumn 45, Issue 6, 1998, Pages 365-368

  Akpolat, I ^a   Baris Y S ^a   Yilmaz, A F ^b   Bakirtas M ^a   Saylik, A ^a   Karagoz F ^a   Kandemir, B ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b NONE

Author keywords

AgNORs; Bladder carcinoma; Cathepsin B; p53

Indexed keywords

CATHEPSIN B; PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; CHROMOSOME NOR; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PROTEIN EXPRESSION; STROMA CELL; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

EID: 0032449470     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. AALTOMAA, S., LIPPONEN, P., SYRJANEN, K.: Nucleolar organiser regions related to morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis in female breast cancer. Pathol. Res. Pract., 189, 1993, 416-421.
2. AKPOLAT, I., EREKUL, S., KOBAT, I., BACACI, K.: Vimentin, AgNORs and estrogen-receptor-related protein-29 in breast carcinoma. Tumori, 81, 1995, 302.
3. CAMPO, E., MUNOZ, J., MIQUEL, R., PALACIN, A., CARDESA, A., SLOANE, B.F., EMMERT-BUCK, M.R.: Cathepsin B expression in colorectal carcinomas correlated with tumor progression and shortened patient survival. Am. J. Pathol, 145, 1994, 301-309.
4. CROCKER, J., BODY, D.A.R., EGAN, M.J.: How should we count AgNORs? Proposals for a standardized approach. J. Pathol., 158, 1989, 185-188.
5. DALBAGNI, G., PRESTI, JR. J.C., REUTER, V.E., ZHANG, Z.F., SARKIS, A.S., FAIR, W.F., CORDON-CARLOS, C.: Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer. Diagn. Mol. Pathol., 2, 1993, 4-13.
6. EGAN, M.J., CROCKER, J.: Nucleolar organiser regions in pathology. Br. J. Cancer, 65, 1992, 1-7.
7. ESRIG, D., SPRUCK, C.H.III, NICHOLS, P.W., CHAIWUN, B., STEVEN, K., GROSHEN, S., CHEN, S.C., SKINNER, O.G., JONES, P.A., COTE, R.J.: p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am. J. Pathol., 143, 1993, 1389-1397.
8. HIGASHIYAMA, M., DOI, K., KODAMA, K., YOKOUCHI, H., TATEISHI, R.: Cathepsin B expression in tumour cells and laminin distribution in pulmonary adenocarcinoma. J. Clin. Pathol., 46, 1993, 18-22.
9. LIMAS, C., BIGLER, A., BAIR, R., BERNHART, P., REDDY, F.: Proliferative activity of urothelial neoplasms: Comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions. J. Clin. Pathol., 46, 1993, 159-165.
10. NADJI, M., FRESNO, M., NASSIRI, M., CONNER, G., HERRERO, A., MORALES, A.R.: Cathepsin D in host stromal cells, but not in tumor cells, is associated with aggressive behavior in node negative-breast cancer. Hum. Pathol., 27, 1996, 890-895.
11. OTTO, T., BIRCHMEIER, W., SCHMIDT, U., HINKE, A., SCHIPPER, J., RUBBEN, H., RAZ, A.: Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res., 54, 1994, 3120-3123.